Puma Biotechnology Inc. (PBYI) at a glance

Puma Biotechnology Inc. (PBYI) is a small-cap Healthcare company. It trades at $9.07, with a P/E of 15.3, a 10.7% profit margin and revenue decline of 2.6%. It does not pay a dividend. Vestovix scores it 52/100 overall. Its strongest dimension is Momentum (81/100) and its weakest is Growth (34/100). Its volatility is roughly in line with the market.

Price

$9.08

Market cap

$373.1M

P/E ratio

15.3

Dividend yield

None

Beta

1.21

52-week range

$4.30 to $9.51